Pluristem Therapeutics INITIATED at Buy and 3 Analyst-Initiated Shares to Note

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on July 25th.

Fed Investors (NYSE:FII): RBC Capital Mkts initiated coverage of this company with a rating of Underperform and a price target of $19.

Don’t Miss: Ford Earnings: Profit Falls, Yet Revenue TOPS Analyst Estimate.

Eaton Vance (NYSE:EV): RBC Capital Mkts initiated coverage of this company with a rating of Sector Perform and a price target of $28.

BlackRock (NYSE:BLK): RBC Capital Mkts initiated coverage of this company with a rating of Outperform and a price target of $221.

Pluristem Therapeutics (NASDAQ:PSTI): Maxim Group initiated coverage of this company with a rating of Buy and a price target of $8.

Don’t Miss: Is Apple Getting Bitten in China?

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business